Skip to content
★ Sign in to follow
Vaishali Pharma Limited logo

Vaishali Pharma Limited Stock: price and insider trades · India

IN·Mcap ₹896.3MHealth Care

Vaishali Pharma Limited: what insiders have been doing

Every trade that managers of Vaishali Pharma Limited disclose to SEBI (PIT + SAST) is tracked on this page. The company sits in the Health Care sector. The last twelve months, up to 24 October 2026, brought 1 filing signed by 1 insider.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Across the 1,892 companies tracked on its exchange, the median is 4 filings; at 1 filing, this issuer sits below that mark. The full history, which starts in 2022, counts no purchases against 3 sales.

There has been no open-market purchase by an insider of Vaishali Pharma Limited for at least a year.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.

Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€1M
3 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 17,613 of 26,897 companies
41.4
score / 100
Value
46
Quality
37
FCF yld-0.0%
Earn yld4.5%
EV/EBITDA13.5x
ROE6.2%
Gross mgn9.2%
Net mgn3.8%
Debt/EBITDA2.4x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹6.87
Analyst consensus
·
Income statement
Revenue₹1B
Gross profit₹96.3M9% margin
EBITDA₹79.7M8% margin
Net income₹40.3M4.1% margin
Valuation
PER (trailing)122.5x
P/Book1.3x
Beta0.36
Balance sheet & cash
Market cap₹896.3M
Total debt₹188.9M
Free Cash Flow-₹233k
Debt / Equity27%
Profitability & ownership
ROE6.2%
ROA1.9%
Last declaration on 10 July 2026
Declarations6 total
  • ●
    Related company / holdingExecutives
    0SEBI
    4,537,865 sharesEquity sharesPreferential AllotmentSEBI:b2e2dc260fc1032921ab8243da22c199210f16e0
  • ●
    Executives
    2M INR10SEBI
    200,000 shares@ ₹10.00100.0% of flowEquity SharesSEBI:3c57a961dc7531f9de9373868db2604ad9c53860
  • ▼
    Executives
    6M INR22SEBI
    1,000,000 shares@ ₹5.839100.0% of flowEquity SharesSEBI:f7f2226638513994f22256e075d03b9ce879243e
  • ▼
    Executives
    83M INR22SEBI
    1,552,593 shares@ ₹53.2818100.0% of flowEquity SharesSEBI:e8884607265fc823b69e8874c192fe063230d608
  • ▼
    Executives
    26M INR10SEBI
    630,000 shares@ ₹41.75100.0% of flowEquity SharesSEBI:fa1c03013e1b7a608864857899564acff055f971
  • ●
    Executives
    2M INR10SEBI
    64,741 shares@ ₹38.0185100.0% of flowEquity SharesSEBI:dcba59e91d9726b85efe698d0310d989ce77c25a

6 of 6 declarations

About Vaishali Pharma Limited

Vaishali Pharma Limited is a company operating in the healthcare and pharmaceutical sector. It is listed on the XBOM market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations